Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis have?
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis has 177 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis published?
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis has 2020 year in the ScholarIQ index.
What is the open-access status of Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis?
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis has hybrid oa status in the ScholarIQ index.
What is the DOI of Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis?
The DOI for Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis is on the source record.
What is the PMID of Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis?
The PMID for Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis is on the source record.
What is the OpenAlex record for Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis?
The OpenAlex for Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis is on the source record.